A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

[1]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[2]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[3]  R. Melamed,et al.  Gene expression microarrays: glimpses of the immunological genome , 2006, Nature Immunology.

[4]  D A Isenberg,et al.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.

[5]  Christophe Benoist,et al.  A Plaidoyer for ‘Systems Immunology’ , 2006, Immunological reviews.

[6]  J. Ware,et al.  Applied Longitudinal Analysis , 2004 .

[7]  Frank Harary,et al.  Graph Theory , 2016 .

[8]  Stefan Michiels,et al.  Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.

[9]  Virginia Pascual,et al.  Analysis of Significance Patterns Identifies Ubiquitous and Disease‐Specific Gene‐Expression Signatures in Patient Peripheral Blood Leukocytes , 2005, Annals of the New York Academy of Sciences.

[10]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[11]  D. Koller,et al.  From signatures to models: understanding cancer using microarrays , 2005, Nature Genetics.

[12]  Manuel Hidalgo,et al.  Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[14]  V. Pascual,et al.  Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade , 2007, The Journal of experimental medicine.

[15]  M. Crow,et al.  Microarray Analysis of Interferon-regulated Genes in SLE , 2003, Autoimmunity.

[16]  A. Claudy,et al.  Disease activity in systemic lupus erythematosus , 1979, Clinical and experimental dermatology.

[17]  T. Barrette,et al.  Mining for regulatory programs in the cancer transcriptome , 2005, Nature Genetics.

[18]  M. Cotreau,et al.  Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. , 2006, The Journal of molecular diagnostics : JMD.

[19]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[20]  M. Peterson,et al.  Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[21]  D. Chaussabel,et al.  Mining microarray expression data by literature profiling , 2002, Genome Biology.

[22]  R. Steinman,et al.  Immunotherapy: Bewitched, Bothered, and Bewildered No More , 2004, Science.

[23]  Sandra Healy,et al.  Cross platform microarray analysis for robust identification of differentially expressed genes , 2007, BMC Bioinformatics.

[24]  Petri Auvinen,et al.  Are data from different gene expression microarray platforms comparable? , 2004, Genomics.

[25]  Maqc Consortium.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[26]  John Quackenbush,et al.  Multiple-laboratory comparison of microarray platforms , 2005, Nature Methods.

[27]  S. Y. Kim,et al.  Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus , 2001, Lupus.

[28]  D. Isenberg,et al.  Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. , 1992, Clinical and experimental rheumatology.

[29]  Mimi Y. Kim,et al.  Classification and definition of major flares in SLE clinical trials , 1999, Lupus.

[30]  C. Tibbetts,et al.  Surveillance of transcriptomes in basic military trainees with normal, febrile respiratory illness, and convalescent phenotypes , 2005, Genes and Immunity.

[31]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[32]  James G Krueger,et al.  Combining several ordinal measures in clinical studies , 2004, Statistics in medicine.

[33]  E. Schned,et al.  Derivation of the SLEDAI. , 1993, Arthritis and rheumatism.

[34]  J. Ioannidis.  Microarrays and molecular research: noise discovery? , 2005, The Lancet.

[35]  Virginia Pascual,et al.  Gene expression in peripheral blood mononuclear cells from children with diabetes. , 2007, The Journal of clinical endocrinology and metabolism.

[36]  Bryan Frank,et al.  Independence and reproducibility across microarray platforms , 2005, Nature Methods.

[37]  D. Koller,et al.  A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.

[38]  Mehmet Toner,et al.  Application of genome-wide expression analysis to human health and disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Hofker.  Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. , 2003 .

[40]  Kathleen F. Kerr,et al.  Standardizing global gene expression analysis between laboratories and across platforms , 2005, Nature Methods.

[41]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[42]  K. Wittkowski,et al.  Opiate-like effects of sugar on gene expression in reward areas of the rat brain. , 2004, Brain research. Molecular brain research.

[43]  J. Banchereau,et al.  Gene expression patterns in blood leukocytes discriminate patients with acute infections. , 2007, Blood.

[44]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[45]  G. Molenberghs,et al.  Linear Mixed Models for Longitudinal Data , 2001 .

[46]  Oliver Bendel.  [E] , 1896, Les noms officiels des communes de Wallonie, de Bruxelles-Capitale et de la communaute germanophone.

[47]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.